A popular diabetes medication made by Novo Nordisk has been approved to be sold in the U.S. as a weight-loss drug by the Food and Drug Administration, the Associated Press reported on Friday.
Dr. Harold Bays, medical director of the Louisville Metabolic and Atherosclerosis Research Center, helped run the studies on Wegovy, as well as other obesity and diabetes drugs. Dropping even five percent of one's weight can bring health benefits, such as improved energy, blood pressure, blood sugar and cholesterol levels, but it often doesn't satisfy patients who are focused on weight loss, Bays said.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: